Compare GALT & AIIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GALT | AIIA |
|---|---|---|
| Founded | 2000 | 2025 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 193.9M |
| IPO Year | 2008 | N/A |
| Metric | GALT | AIIA |
|---|---|---|
| Price | $2.53 | $10.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 348.5K | 21.7K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $9.87 |
| 52 Week High | $7.13 | $10.24 |
| Indicator | GALT | AIIA |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 57.12 |
| Support Level | $2.09 | $10.05 |
| Resistance Level | $2.60 | $10.24 |
| Average True Range (ATR) | 0.23 | 0.02 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 44.71 | 77.78 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
AI Infrastructure Acquisition Corp is a blank check company.